StockComparison Logo
vs

MXCT vs DBTX

Comparison between MaxCyte Inc (MXCT, Company) and Decibel Therapeutics Inc (DBTX, Company).

MXCT vs DBTX - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
MXCT
$123M
DBTX
$123M
Max Drawdown
MXCT
96.07%
Winner
DBTX
90.70%
Sharpe Ratio
MXCT
-0.66
Winner
DBTX
0.64
5Y Beta
MXCT
1.28
DBTX
N/A
Industry
MXCT
Medical Devices
DBTX
N/A
P/E Ratio
Winner
MXCT
-3.14
DBTX
-1.94
5Y EPS CAGR
MXCT
12.02%
DBTX
N/A
Debt to Equity
Winner
MXCT
0.00%
DBTX
0.18%
Free Cash Flow Yield
Winner
MXCT
-23.83%
DBTX
-40.16%
P/S Ratio
MXCT
3.62
DBTX
N/A
P/B Ratio
Winner
MXCT
0.73
DBTX
2.30

MXCT vs DBTX - Historical Returns

Returns include dividend reinvestment.

1M
Winner
MXCT
+36.22%
DBTX
-4.47%
3M
Winner
MXCT
+34.13%
DBTX
+22.75%
6M
MXCT
-26.32%
Winner
DBTX
+85.28%
1Y
MXCT
-50.66%
Winner
DBTX
+24.30%
5Y(CAGR)
MXCT
-28.14%
DBTX
N/A
Max(CAGR)
Winner
MXCT
-5.26%
DBTX
-39.19%

MXCT vs DBTX - Annual Returns (2019 - 2026)

Returns include dividend reinvestment.

YearMXCTDBTX
2026-27.74%N/A
2025-62.65%N/A
2024-16.80%N/A
2023-8.20%+136.63%
2022-49.63%-59.24%
2021+525.15%-74.21%
2020+0.00%N/A
2019+2.31%N/A

MXCT vs DBTX Drawdown Comparison

The maximum drawdown for MXCT was -96.07%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The maximum drawdown for DBTX was -90.70%, occurring on May 9, 2022. This drawdown has not yet recovered.

The current MXCT drawdown is -93.49%. The current DBTX drawdown is -75.33%.

RankMXCTDBTX
#1-96.07%
Sep 3, 2021 - Mar 30, 2026		-90.70%
Feb 22, 2021 - May 9, 2022
#2-37.58%
Jan 22, 2021 - Jul 30, 2021		N/A
#3-19.65%
Jul 30, 2021 - Sep 3, 2021		N/A

Correlation

Correlation between MXCT and DBTX is 0.40 which considered as a weak positive correlation - the stocks show a slight tendency to move together.

0.40
-101

Select Stocks to Compare

Popular: MXCT vs SPYDBTX vs SPY